Latest Quest Diagnostics News & Updates

See the latest news and media coverage for Quest. We track all announcements, press releases, and industry mentions in real time, all in one place.

Quest Diagnostics (Quest)

Medical diagnostic testing and laboratory services provider

questdiagnostics.com

Headquarters: Secaucus, United States
Founded year: 1967
Company type: Public company
Number of employees: 30,000+
Industry: Healthcare Facilities & Services

Last updated Today

Latest news about Quest Diagnostics (Quest)

In short: Quest Diagnostics reported strong 2026 financial growth, raised its full-year outlook, and expanded its advanced testing and AI capabilities.

Company announcements

July 23 Quest

Quest reports Q2 2026 revenue up 10.2%, raises guidance

Second quarter diluted EPS rose to $2.84, and adjusted EPS to $3.12. Revenue reached $3.04 billion, with organic growth of 10%.

July 10 Quest

One in five workers had positive hair drug test in 2025

Hair test positivity for marijuana rose 58.9% over five years, while overall urine positivity stayed above 4%.

July 8 Quest

Quest extends oncology test access through OncoEMR MPI

A pilot program with American Oncology Network provides access to Haystack MRD and comprehensive genomic profiling.

June 29 Quest

Quest Diagnostics Foundation commits $5 million to Miami-Dade health and food security

Grants to four nonprofits aim to reach 15,000 residents over two years with testing, community health workers, and nutritious food.

Media coverage

July 26 Yahoo Finance

Why Quest Diagnostics (DGX) Is Up 8.2% After Raising 2026 Guidance And Boosting Buybacks

Earlier this week, Quest Diagnostics reported second-quarter 2026 results showing sales of US$3,043 million and diluted EPS of US$2.84, and raised its full‑year 2026 revenue...

July 24 Yahoo Finance

JPMorgan Adjusts Price Target on Quest Diagnostics to $250 From $220, Maintains Neutral Rating

Learn more Quest Diagnostics (DGX) has an average rating of overweight and mean price target of $244.93, according to analysts polled by FactSet.

July 23 StocksToTrade

Quest Diagnostics Stock Gains As Oncology Moves Impress Wall Street - StocksToTrade

By integrating Haystack MRD and ... OncoEMR, Quest Diagnostics is putting its tests directly in front of oncologists where they live — inside the chart...

July 23 The Globe and Mail

Why Quest Diagnostics Stock Climbed This Past Week

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.

Never miss news about Quest

Track Quest and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Quest competitors & trending companies

Browse news for competitors to Quest and other trending companies.